The American healthcare system is navigating a treacherous legal landscape where the aftershocks of 2025's regulatory shifts have merged with new, technologically driven challenges, creating an environment of unprecedented complexity for employers. As the industry grapples with the continuation of
The Food and Drug Administration's Center for Devices and Radiological Health (CDRH) has presented a picture of remarkable operational stability in its 2025 annual report, successfully maintaining its core device review functions despite navigating significant internal pressures and substantial
The transition from a hospital to a post-acute care setting often represents a critical yet vulnerable point in a patient's journey, where fragmented information can lead to significant risks, including medication errors and preventable readmissions. In a healthcare ecosystem striving for
A recent state audit has unearthed a staggering financial blunder within a single New Jersey school district, revealing that nearly fifty million dollars in potential savings on employee health insurance were completely squandered over just four years. This incident in Perth Amboy is not an
The medical technology landscape witnessed an unprecedented wave of consolidation and strategic realignment in 2025, with merger and acquisition activity skyrocketing to approximately $80 billion by the end of November. This remarkable figure, which eclipsed the combined deal values of the
The health insurance sector experienced a seismic shock on January 27, 2026, as a startling government proposal sent stock values tumbling and cast a long shadow over the future of a program serving millions of American seniors. The catalyst for this market upheaval was a report from the Centers
